The active ingredient of smart cancer drugs produced abroad was developed domestically

Feb. 19, 2025

Important step for domestic cancer drug.

Robot developed to accelerate cell studies

Dec. 27, 2024

IBG research group leader Dr Arif Engin Çetin and his team developed a robot to combine sample preparation and cell development imaging processes, which are carried out separately in cancer and drug research in laboratories, on a single platform.

Device developed to eliminate degenerative tissues before they turn into cancer

Dec. 4, 2024

Assoc. Prof. Serhat Tozburun and his team at IBG developed a device to eliminate abnormal tissues carrying cancer risk in the digestive system in the Clarisurge project with a grant of €1.6 million from the ERC Consolidator Grant supported by TÜBİTAK.

2024 IBG Science Day: Inspirational meeting

Nov. 26, 2024

2024 IBG Science Day, held on 25 November 2024 at the IBG, brought together scientists, students and researchers from all over Türkiye with the scientific support of the Neuroscience Society of Turkey (TÜBAS).

Applications for the IBG Science Medal are now open: Award for researchers who inspire science

Oct. 7, 2024

Izmir Biomedicine and Genome Center (IBG) has opened applications for the prestigious IBG Science Medal. The award aims to honour scientists who contribute to society through innovative research in the life sciences.

Climate change and environmental pollutants discussed at EXPOSOME-TR Symposium

Sept. 27, 2024

EXPOSOME-TR Symposium, where the effects of climate change and environmental pollutants on human health were discussed in Izmir, was held in cooperation with Izmir Biomedicine and Genome Center (IBG) and Dokuz Eylül University (DEU).

DMD Symposium held at Izmir Biomedicine and Genome Center

Sept. 23, 2024

The Duchenne Muscular Dystrophy (DMD) Symposium was held at IBG as part of the Rare Neuromuscular Disease Awareness Month. This event, organized in collaboration with IBG-RareBoost and Hedef DMD projects, aims to raise awareness.

Domestic biotech cancer drugs are on the way

Sept. 3, 2024

Significant progress was achieved to overcome foreign dependency in pharmaceuticals. Turkish scientists have started to develop domestic drugs. Important studies are being carried out at IBG, to develop biotechnological drugs for cancer.

New IBG project: Innovative drug delivery system for treating bile duct cancer

Aug. 21, 2024

IBG is undertaking a new project to develop a biotechnological drug carrier system for biliary tract cancer patients. The project has been accepted within the TÜBİTAK-2515 COST Support Program.

Turkish researchers have access to supercomputers to find solutions to genetic diseases

July 1, 2024

The team of researchers from Izmir Biomedicine and Genome Center, which has gained access to the 'MareNostrum5' supercomputer developed as part of The European High Performance Computing Joint Undertaking, will find solutions to genetic diseases.

IBG hosts seminar on rare diseases and biobanking training

June 15, 2024

Helene and Mikk Cederroth, who work on rare and undiagnosed diseases in Sweden, gave a seminar at IBG. A training on Biobanking was also organized at IBG on 10-12 June.

A major development in the treatment of ovarian cancer

May 22, 2024

The research team at Izmir Biomedicine and Genome Center has developed a new drug model that does not harm healthy cells in the treatment of ovarian cancer. The model has received a patent.

A big step forward for the domestic and national meningitis vaccine

April 28, 2024

Under the leadership of the Izmir Biomedicine and Genome Center (IBG), researchers from Bilkent and Hacettepe Universities have developed a new generation method for a highly protective and affordable meningitis vaccine.

350 million people worldwide are living with an undiagnosed disease.

April 26, 2024

29 April World Undiagnosed Disease Day, aims to raise public awareness by drawing attention to undiagnosed diseases and to improve diagnosis by encouraging national or international cooperation.

DR. ARİF ENGİN ÇETİN’S RECENTLY DEVELOPED TECHNOLOGY WAS WELL RECEIVED BY THE PRESS

Dec. 30, 2022

Turkish scientists developed a new technology for the diagnosis of Familial Mediterranean Fever (FMF) in a project led by Dr. Arif Engin ÇETİN, the group leader IBG Nanophotonics and Bioidentification Systems Laboratory

NOVEMBER 10th IBG SCIENCE HELD IN HYBRID FORMAT DREW ATTENTION OF PRESS AS WELL

Nov. 15, 2022

The "November 10th IBG Science Day", which we traditionally celebrate to commemorate the founder of the Republic, Gazi Mustafa Kemal Atatürk, hosted science lovers at IBG Center and online as the event is also held in a hybrid format.

ASSOC. PROF SERHAT TOZBURUN’S RECENTLY DEVELOPPED AND PATENTED TECHNOLOGY WAS WELL RECEIVED BY THE PRESS

Sept. 2, 2022

Assoc. Prof. Serhat Tozburun and his team succeeded at developing diagnostic methods such as ultrasound and laser scanning imaging by developing a technology that can simultaneously display blood flow rates in different vessels.

INTERVIEW IN DETTO YORUM MAGAZINE

Jan. 24, 2022

IBG Neuro-genomics Lab research group leader Dr. Yavuz OKTAY and IBG-Bioinformatics Platform director Assoc. Prof. Gökhan KARAKÜLAH talked about the start-up they established in DEPARK, and its product.

STEM CELL AND ORGANOID TECHNOLOGIES LAB IN MEDIMAGAZIN

Dec. 14, 2021

The translational work and projects of Prof. Dr. Esra ERDAL and her group were featured in the latest issue of Medimagazin.

THE AGREEMENT SIGNED AMONG IBG/OZBIO AND NOBEL PHARMACEUTICALS RECEIVED WIDE MEDIA COVERAGE

Nov. 15, 2021

The important agreement in which four institutions came together for a medicine, that will be produced in Turkey, attracted attention in the media.

ASSOC. PROF SERHAT TOZBURUN’S APPROVED PATENT WAS WELL RECEIVED BY THE PRESS

Nov. 12, 2021

The news of the approved patent of the device, which was developed to facilitate the diagnosis of diseases in difficult areas of the eye, was published in important media channels.

IBG FEATURES IN SANAYI NEWSPAPER

June 15, 2021

The newspaper specialised in the industry field, Sanayi, published an article about IBG in its 552nd issue.

TRT HABER NEWS CHANNEL INTERVIEWS MEMBERS OF IBG-BIOBANK ON BIOBANKS

April 5, 2021

TRT Haber News Channel Interviews Members of IBG-Biobank on Biobanks

THE STORY OF A RARE DISEASE PATIENT RECEIVES MEDIA COVERAGE

April 5, 2021

The team involving researchers Dr. Yavuz OKTAY and Prof. Dr. Semra HIZ from Izmir Biomedicine and Genome Center and Dokuz Eylul University (DEU) conducted research which has given chance at life to Yakup Altun and his two cousins who have a rare disease.

IBG FEATURES IN ANAHTAR, THE MONTHLY JOURNAL OF MINISTRY OF INDUSTRY

March 15, 2021

Anahtar, which is the monthly publication of the Ministry of Industry and Technology of Turkey, published an article about Izmir Biomedicine and Genome Center in its March 2021 issue.

DR. ARIF ÇETIN’S “TUSEB AZIZ SANCAR ENCOURAGEMENT AWARD” WAS PUBLISHED IN THE PRESS

Jan. 8, 2021

TUSEB AZIZ SANCAR ENCOURAGEMENT AWARD

THE RESEARCH STUDY OF ASSOC. PROF. DUYGU SAG AND HER PARTNERS ON A NEW IMMUNOSTIMULANT MOLECULE WAS WELL RECEIVED BY THE PRESS

Jan. 8, 2021

The Research Study on a new immunostimulant molecule was well received by the press.

Protein-based original drug development was launched at Izmir Biomedicine and Genome Center

Sept. 8, 2020

IBG, the establishment of which began almost 20 years ago under Dokuz Eylul University (DEU) and which receives funding from many organisations such as TUBITAK, became one of Turkey’s first four thematic research centres in 2018.

Drug Analysis and Control Laboratories were launched at Izmir Biomedicine and Genome Center

Aug. 17, 2020

Turkey’s first Drug Analysis and Control Laboratories with a GLP certificate were launched in Izmir

First Animal Tests for the Coronavirus Vaccination Gave Positive Results

Aug. 17, 2020

IBG Director Prof. Dr. Ozturk stated that they have obtained positive results from the laboratory experiments and animal testing in relation to the work conducted on vaccination, prophylactic and medicinal drugs during the Covid-19 process.

Mehmet Öztürk: Whatever is done to produce the vaccine all around the world; is also being done in our center...

June 22, 2020

CUMHURIYET'S INTERVIEW WITH IBG DIRECTOR PROF. DR. MEHMET OZTURK

Turkish scientists have developed a portable microscope with high-resolution imaging

Feb. 24, 2020

Using the imaging features of mobile phones, a battery-operated microscope which can enlarge images more than commercial microscopes was developed at Izmir Biomedicine and Genome Center.

Turkish scientists have developed a portable device that is able to detect the H1N1 virus in 5 minutes

Jan. 29, 2020

A local and national portable device was manufactured to be able to detect the H1N1 virus. The work conducted to develop the device lasted a total of 1.5 years, including the process to set up the chemical and biological protocols required by the system.

Significant step from Izmir Biomedicine and Genome Center towards the production of local pharmaceuticals

Dec. 30, 2019

Izmir Biomedicine and Genome Center has succeeded in becoming Turkey’s first drug analysis laboratory entitled to obtain the GLP certificate required to run preclinical tests on molecules developed by Turkish companies for locally produced drugs.

Meaningful Cooperation in the Pharmaceutical Industry

Nov. 20, 2019

Izmir Biomedicine and Genome Center (IBG), Turkey’s first thematic research center in the healthcare field, and pharmaceutical company Merck have signed a joint declaration of labour.

Mustafa Kemal Atatürk, founder of the Republic of Turkey, was commemorated with IBG Science Day on November 10th

Nov. 15, 2019

Izmir Biomedicine and Genome Center (IBG), Turkey’s first thematic research center in the healthcare field, hosted ‘10th of November IBG Science Day’ to commemorate Mustafa Kemal Atatürk with science on the 81st anniversary of his death.

Orhan Bursalı: Women scientists are rapidly becoming prominent...

Nov. 14, 2019

İzmir’deki bilim şenliğinde salonu dolduran kalabalığa bakıyorum, genç kadınlar çoğunlukta gözüküyor. Bu yeni bir gözlemim değil. İzmir Biyotıp ve Genom Merkezi’nde (İBG) bulunan araştırma gruplarına liderlik yapanların yarısı kadın.

Kadın Biliminsanları, İBG-Merck Anlaşması

Scientifically honorable moments and IBG

Nov. 14, 2019

İzmir Biyotıp ve Genom Merkezi (IBG) 10 Kasım’ı, çok anlamlı ve bilim madalyası da verdiği bilimsel bir şölenle kutladı.

November 10 IBG Science Day

Minister of Industry and Technology Mustafa Varank visited IBG

Nov. 10, 2019

Minister of Industry and Technology Mustafa Varank, Izmir Deputy Hamza Dağ, President of TUBITAK Prof. Dr. Hasan Mandal, Izmir Governor Erol Ayyıldız and the Governor of Balçova Süleyman Özçakıcı visited IBG on Wednesday, 09 October 2019.

PROF. DR. MEHMET ÖZTÜRK'S SPEECH ON BIOTECHNOLOGICAL DRUGS FOR THE EKONOMIST MAGAZINE

Nov. 9, 2018

PROF. DR. MEHMET ÖZTÜRK'S SPEECH ON BIOTECHNOLOGICAL DRUGS FOR THE EKONOMIST MAGAZINE

UNESCO-LOREAL INTERNATIONAL RISING TALENT: DUYGU SAĞ

March 26, 2018

Assoc.Prof. Duygu Sağ, an immunology group leader at Izmir Biomedicine and Genome Center (IBG), is one of the 15 promising female scientists recognized as ‘International Rising Talents’ this year by the L’Oréal-UNESCO for Women in Science Programme

IS LOVE GENETIC?

Dec. 26, 2017

Prof. Mehmet Öztürk attracts attention with his speech.

Genetics, Scientific Talks

IBG featured in the ‘Science and Technology for All’ (HBT) weekly science magazine

Dec. 12, 2017

Editor Orhan Bursalı’s report on IBG and his interview with our director Prof. Dr. Mehmet Ozturk (in Turkish).

Hürriyet Ege: “Izmir Biomedicine and Genome Center is Equivalent to Harvard”

Nov. 19, 2017

From Ayçe DİKMEN:

TUBITAK AND TUBA 2021 SCIENCE AWARDS CEREMONY

None

At the award ceremony held under the auspices of T.C. President Recep Tayyip ERDOĞAN, IBG research group leader Dr. Arif Engin ÇETİN received the incentive award from the President.